Funder: Alliance for Cancer Gene Therapy

Due Dates: May 15, 2026 (Letter of Intent/Abstract) | September 1, 2026 (Full application, invited only)

Funding Amounts: Up to $500,000 total over 2–3 years, including up to 10% indirect costs.

Summary: Supports innovative translational research to overcome barriers in cell and gene therapy for solid tumor cancers.

Key Information: LOI required; research must be conducted at US or Canadian institutions.